These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3838080)

  • 1. Loss of suppression of normal bone marrow colony formation by leukemic cell lines after differentiation is induced by chemical agents.
    Steinberg HN; Tsiftsoglou AS; Robinson SH
    Blood; 1985 Jan; 65(1):100-6. PubMed ID: 3838080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemin stimulating effect on colony formation of leukemic and bone marrow cells.
    Rothmann J; Hertogs CF; Malik Z; Pluznik DH
    Exp Hematol; 1983 Feb; 11(2):147-53. PubMed ID: 6403366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microenvironmental toxicity of azidothymidine: partial sparing with hemin.
    Abraham NG; Bucher D; Niranjan U; Brown AC; Lutton JD; Distenfeld A; Ahmed T; Levere RD
    Blood; 1989 Jul; 74(1):139-44. PubMed ID: 2752105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells.
    Roodman GD; Bird A; Hutzler D; Montgomery W
    Exp Hematol; 1987 Oct; 15(9):928-35. PubMed ID: 2820776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inducers of erythroid differentiation of human leukemia K562 cells on vincristine-resistant K562/VCR cells.
    Okabe-Kado J; Hayashi M; Honma Y; Hozumi M; Tsuruo T
    Leuk Res; 1983; 7(4):481-5. PubMed ID: 6684716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities derived from established human myeloid cell lines reverse the suppression of cell line colony formation by lactoferrin and transferrin.
    Broxmeyer HE; Rubin BY; Berman E; Juliano L; Lu L; Hast LJ; Cooper S; Singer JW
    Exp Hematol; 1986 Jan; 14(1):51-9. PubMed ID: 3455916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma constitutively expressed in the stromal microenvironment of human marrow cultures mediates potent hematopoietic inhibition.
    Selleri C; Maciejewski JP; Sato T; Young NS
    Blood; 1996 May; 87(10):4149-57. PubMed ID: 8639773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of granulocyte-macrophage progenitor cells (CFU-C) and fibroblastoid colony-forming units (CFU-F) by leukemic cells in human and murine leukemia.
    Nara N; Jinnai I; Imai Y; Bessho M; Hirashima K
    Acta Haematol; 1984; 72(3):171-80. PubMed ID: 6438981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity.
    Degliantoni G; Perussia B; Mangoni L; Trinchieri G
    J Exp Med; 1985 May; 161(5):1152-68. PubMed ID: 3838767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta selectively inhibits normal and leukemic human bone marrow cell growth in vitro.
    Sing GK; Keller JR; Ellingsworth LR; Ruscetti FW
    Blood; 1988 Nov; 72(5):1504-11. PubMed ID: 2460153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemin-induced erythroid differentiation changes the sensitivity of K562 cells to tumor necrosis factor-alpha.
    Li XF; Anderson J; Hutzler D; Roodman GD
    Exp Hematol; 1989 Dec; 17(11):1059-62. PubMed ID: 2555212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of members of the Wnt gene family in human hematopoiesis.
    Van Den Berg DJ; Sharma AK; Bruno E; Hoffman R
    Blood; 1998 Nov; 92(9):3189-202. PubMed ID: 9787155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trauma inhibits erythroid burst-forming unit and granulocyte-monocyte colony-forming unit growth through the production of TGF-beta1 by bone marrow stroma.
    Wu JC; Livingston DH; Hauser CJ; Deitch EA; Rameshwar P
    Ann Surg; 2001 Aug; 234(2):224-32. PubMed ID: 11505069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of hemin enhancement of burst-forming units-erythroid clonal efficiency by progenitor cells from normal and HIV-infected patients.
    Abraham NG; Mathew A; Jiang S; Lutton JD; Nishimura M; Chertkov JL; Levere RD
    Acta Haematol; 1991; 86(4):189-93. PubMed ID: 1805486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
    Ottmann OG; Stella CC; Eder M; Reutzel P; Ströcker S; Hoelzer D; Ganser A
    Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of anti-CD33 blocked ricin immunotoxin on the capacity of CD34+ human marrow cells to establish in vitro hematopoiesis in long-term marrow cultures.
    La Russa VF; Griffin JD; Kessler SW; Cutting MA; Knight RD; Blattler WA; Lambert JM; Wright DG
    Exp Hematol; 1992 May; 20(4):442-8. PubMed ID: 1373688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
    Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
    Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokine-activated killer cells selectively kill tumor cells in bone marrow without compromising bone marrow stem cell function in vitro.
    van den Brink MR; Voogt PJ; Marijt WA; van Luxemburg-Heys SA; van Rood JJ; Brand A
    Blood; 1989 Jul; 74(1):354-60. PubMed ID: 2787676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.